Knowledge Distillery

Severe COVID-19 is associated with dysregulated inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, plus…

NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length…

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have been postulated to affect susceptibility to COVID-19.…

In this paper, recently published in the Journal of Neurology, Neurosurgery and Psychiatry, the authors report initial findings of an ongoing…

In this longitudinal study, recently published in the European Journal of Neurology, the authors sought to describe the neurological manifestations of…

In this paper, recently published in Neurocritical Care, the authors conducted a retrospective cohort study of patients with haemorrhagic stroke (both…

In this paper, recently published in Stroke, the authors aimed to compare anterior circulation large vessel occlusion stroke severity between patients…

On 21 February 2020, a resident of the municipality of Vo’, a small town near Padua (Italy), died of pneumonia due to severe acute respiratory…

Little is known about the nature and durability of the humoral immune response to infection with SARS-CoV-2.

The objective of this longitudinal cohort study recently published in JAMA Network Open, was to identify excess risk and risk factors associated with…

The objective of this prospective meta-analysis recently published in JAMA was to estimate the association between administration of corticosteroids…

Clinical outcome following infection with SARS-CoV-2 ranges from silent infection to lethal COVID-19.